Clinical Trial Update: Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients

View source ↗

Summary

A real-world study in China is recruiting to evaluate irinotecan hydrochloride liposome injection II for pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Irinotecan hydrochloride liposome injection (II) (irinotecan liposome injection)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Pancreatic Cancer | Status: RECRUITING